SCHEMBL17035162

SCHEMBL17035162

c1ccc2c(c1)ccc1c3ccccc3nc(-c3ccc(-c4ccc5ccc6cccc7ccc4c5c67)cc3)c21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.41
ERBB2 P04626 1/20 0.41
FYN P06241 1/20 0.41
MAOA P21397 1/20 0.41
ACHE P22303 1/20 0.41
AHR P35869 1/20 0.41
ALDH1A1 P00352 3/20 0.41
HPGD P15428 3/20 0.41
HSD17B10 Q99714 2/20 0.41
THRB P10828 1/20 0.41
KDM4E B2RXH2 2/20 0.36
TOP2A P11388 1/20 0.36
MAPT P10636 1/20 0.36
TNF P01375 1/20 0.35
DHODH Q02127 4/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
TDP1 Q9NUW8 2/20 0.34
LMNA P02545 1/20 0.34
GAA P10253 1/20 0.34
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17034892 0.89 CYP1A2 (0.38) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL17300191 0.89 CYP1A2 (0.44) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL1798919 0.85 CYP1A2 (0.44) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL17034903 0.83 CYP1A2 (0.42) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL17300204 0.82 CYP1A2 (0.39) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL17300208 0.82 CYP1A2 (0.41) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL18748079 0.81 MAPT (0.40) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL17997913 0.81 KDM4E (0.36) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL19051756 0.80 TOP2A (0.36) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL17300226 0.80 CYP1A2 (0.42) CYP1A2ERBB2FYNMAOAACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210143337-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND DISPLAY DEVICE SK MATERIALS CO., LTD. (KR) 2021-05-13 US disclosed
US-20210043843-A1 COMPOUND, ORGANIC LIGHT EMITTING DEVICE, AND DISPLAY DEVICE SK MATERIALS CO., LTD. (KR) 2021-02-11 US disclosed
WO-2019190212-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT DIODE AND DISPLAY DEVICE 에스케이머티리얼즈 주식회사 2019-10-03 WO disclosed
WO-2019182360-A1 COMPOUND, ORGANIC LIGHT-EMITTING DEVICE AND DISPLAY DEVICE 에스케이머티리얼즈 주식회사 2019-09-26 WO disclosed
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210043843-A1 COMPOUND, ORGANIC LIGHT EMITTING DEVICE, AND DISPLAY DEVICE ALDH1A2, L1CAM, OCIAD1 CYP1A2 611/4885ERBB2 2833/4885FYN 4286/4885
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 CYP1A2 1306/4885ERBB2 4664/4885FYN 4776/4885
US-20210143337-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND DISPLAY DEVICE L1CAM, EML4, OCIAD2 CYP1A2 1436/4885ERBB2 3333/4885FYN 4408/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.